about
Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletionsInterleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopeniaPromoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerOptimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow.Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B.Co-stimulatory blockade as therapy for rheumatoid arthritis.Evaluation of splicing efficiency in lymphoblastoid cell lines from patients with splicing-factor retinitis pigmentosa.NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man.IL-7 and lymphopenia.Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels.Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al.A MECP2 missense mutation within the MBD domain in a Brazilian male with autistic disorder.High frequency of nonrecurrent MECP2 duplications among Brazilian males with mental retardation.B cell biomarkers of rituximab responses in systemic lupus erythematosus.Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor.Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?Inhibiting toll-like receptors in inflammatory disease.Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis.Transcriptional profile of native CD271+ multipotential stromal cells: Evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activityT-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for managementQuantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritisDefining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomesThe Analysis of In Vivo Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45lowCD271+ Phenotype
P50
Q21256663-029D05CE-757B-4690-9AA9-6829D53BC1D8Q24798777-ABD990A5-BD50-4A3E-AB12-E2EE5E762B2DQ28218774-BD6CCEF4-8833-458E-8043-9F4787C4BB7DQ30159650-873D8F2D-29B2-4A26-92EC-7BF269B4E59CQ34896371-E1A41E18-BC5E-4CB9-A83E-7B5C857E1E59Q36262484-48DAE96C-ADFB-401F-8766-88BA4FB590C5Q37016489-EFA8F0E3-F650-4B40-8B0A-AEE72688026FQ37580226-B5536505-FFF7-43B4-B0CB-E33A99A5EE9FQ37789936-68D9B2D8-07A7-43B0-B8E9-9E84D9D1C321Q46328588-3ACF4EBC-214F-4104-ABB7-63D495C6C16EQ47696967-4D322A42-9EED-49A3-8E01-CA3E3B87C3D3Q50310723-C08B46FA-5D8C-47EB-847F-08FDC47EEAE3Q50581341-A86D45F8-B0EF-4561-B94A-69F40F5DFB58Q51007054-A3BAD16A-6B9D-4A87-88C0-E59D554E8249Q51075481-4F915A88-4072-4C66-9EEC-ED5A61BB6FE8Q52009888-26428822-5AF1-4D6B-B62E-4A98F6A5AC9BQ52843440-5FCDDC16-B688-4FB6-A18E-EDD475F3B49DQ52847768-FD8A4315-0C99-4B1D-B2B6-5E8EBA2495E3Q52855317-ABA3A94E-096A-43F5-AA6A-C20FFBA032F3Q52859781-D7045515-0B72-4872-9C98-4509C1E2DDEEQ56836036-7289241F-F33A-468B-AEE5-25C0C732907EQ89947863-9B3EDED6-DC90-47AB-9C47-14A53B13CFCDQ91965565-2599CC2A-24A9-44C9-980D-58A355DC857AQ92692647-7B181586-300B-4397-B9CC-ABDA4B60FE56Q92996936-782E948C-61FA-4F07-8005-90391F7B954B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Frederique Ponchel
@af
Frederique Ponchel
@an
Frederique Ponchel
@ast
Frederique Ponchel
@ay
Frederique Ponchel
@az
Frederique Ponchel
@br
Frederique Ponchel
@ca
Frederique Ponchel
@ce
Frederique Ponchel
@ceb
Frederique Ponchel
@co
type
label
Frederique Ponchel
@af
Frederique Ponchel
@an
Frederique Ponchel
@ast
Frederique Ponchel
@ay
Frederique Ponchel
@az
Frederique Ponchel
@br
Frederique Ponchel
@ca
Frederique Ponchel
@ce
Frederique Ponchel
@ceb
Frederique Ponchel
@co
altLabel
frederique ponchel
@en
prefLabel
Frederique Ponchel
@af
Frederique Ponchel
@an
Frederique Ponchel
@ast
Frederique Ponchel
@ay
Frederique Ponchel
@az
Frederique Ponchel
@br
Frederique Ponchel
@ca
Frederique Ponchel
@ce
Frederique Ponchel
@ceb
Frederique Ponchel
@co
P106
P1153
6603779900
P21
P31
P496
0000-0002-3969-7701
P6178
01244665207.96